Skip to main content

Deaths from Medicines: A Systematic Analysis of Coroners’ Reports to Prevent Future Deaths

Abstract

Introduction

Since legislation in 2009, coroners in England and Wales must make reports in cases where they believe it is possible to prevent future deaths. We categorised the reports and examined whether they could reveal preventable medication errors or novel adverse drug reactions.

Methods

We examined 500 coroners’ reports by pre-defined criteria to identify those in which medicines played a part, and to collect information on coroners’ concerns.

Results

We identified 99 reports (100 deaths) in which medicines or a part of the medication process or both were mentioned. Reports mentioned anticoagulants (22 reports), opioids (17), antidepressants (17), drugs of abuse excluding opioids (12 deaths) and other drugs. The most important concerns related to adverse reactions to prescribed medicines (22), omission of necessary treatment (21), failure to monitor treatment (17) and poor systems (17). These were related to defects in education or training, lack of clear guidelines or protocols and failure to implement existing guidelines, among other reasons. Most reports went either to NHS Hospital Trusts or to local trusts. The responses of addressees were rarely published. We identified four safety warnings from the Medicines and Healthcare Products Regulatory Agency that were based on coroners’ warnings.

Conclusion

Coroners’ reports to prevent future deaths provide some information on medication errors and adverse reactions. They rarely identify new hazards. At present they are often addressed to local bodies, but this could mean that wider lessons are lost.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Coroners and Justice Act 2009. c. 25. http://www.legislation.gov.uk/ukpga/2009/25/pdfs/ukpga_20090025_en.pdf. Accessed 15 Jul 2017.

  2. Courts and Tribunal Judiciary. Reports to prevent future deaths. https://www.judiciary.gov.uk/related-offices-and-bodies/office-chief-coroner/pfd-reports/. Accessed 15 Jul 2017.

  3. Coronial Services of New Zealand. https://coronialservices.justice.govt.nz/. Accessed 15 Jul 2017.

  4. Coroners Court of Victoria. http://www.coronerscourt.vic.gov.au/. Accessed 15 Jul 2017.

  5. State Coroner’s Court of New South Wales. http://www.coroners.justice.nsw.gov.au/. Accessed 15 Jul 2017.

  6. Office of the Chief Coroner. Ontario Ministry of Community Services and Correctional Services. http://www.mcscs.jus.gov.on.ca/english/DeathInvestigations/office_coroner/coroner.html. Accessed 15 Jul 2017.

  7. Ministry of Justice. Coroners statistics annual 2015 England and Wales, 12th May 2016. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/525916/coroners-statistics-annual-2015-england-and-wales.pdf. Accessed 15 Jul 2017.

  8. Ministry of Justice. Case 2015-0502. https://www.judiciary.gov.uk/publications/derek-thomas/. Accessed 15 Jul 2017.

  9. Hansard. Psychoactive substances bill (HL), 23 June 2015. https://hansard.parliament.uk/Lords/2015-06-23/debates/15062355000827/PsychoactiveSubstancesBill(HL). Accessed 15 Jul 2017.

  10. MHRA. Citalopram: suspected drug interaction with cocaine; prescribers should consider enquiring about illicit drug use. Drug Saf Update 2016;9 (12):2. https://www.gov.uk/drug-safety-update/citalopram-suspected-drug-interaction-with-cocaine-prescribers-should-consider-enquiring-about-illicit-drug-use. Accessed 15 Jul 2017.

  11. MHRA. Hyoscine butylbromide (Buscopan) injection: risk of serious adverse effects in patients with underlying cardiac disease. Drug Saf Update 2017;10(7):1. https://www.gov.uk/drug-safety-update/hyoscine-butylbromide-buscopan-injection-risk-of-serious-adverse-effects-in-patients-with-underlying-cardiac-disease. Accessed 15 Jul 2017.

  12. MHRA. Spironolactone and renin-angiotensin system drugs in heart failure: risk of potentially fatal hyperkalaemia. Drug Saf Update 2016;9(7):2. https://www.gov.uk/drug-safety-update/spironolactone-and-renin-angiotensin-system-drugs-in-heart-failure-risk-of-potentially-fatal-hyperkalaemia. Accessed 15 Jul 2017.

  13. MHRA. Topical miconazole, including oral gel: reminder of potential for serious interactions with warfarin. Drug Saf Update 2016;9(11):3. https://www.gov.uk/drug-safety-update/topical-miconazole-including-oral-gel-reminder-of-potential-for-serious-interactions-with-warfarin. Accessed 15 Jul 2017.

  14. MHRA. Smoking or a naked flame could cause patients’ dressings or clothing to catch fire when being treated with paraffin-based emollient that is in contact with the dressing or clothing. Drug Saf Update 2016;9(9):9. https://www.gov.uk/drug-safety-update/paraffin-based-skin-emollients-on-dressings-or-clothing-fire-risk. Accessed 15 Jul 2017.

  15. New Zealand Coroners Court. Waetford. (2015) NZCorC 98. 30 Oct 2015. http://www.nzlii.org/cgi-in/sinodisp/nz/cases/NZCorC/2015/98.html?query=waetford. Accessed on 24 Jul 2017.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robin E. Ferner.

Ethics declarations

Funding

No funding was received for this study.

Conflict of interest

Robin E. Ferner has provided medicolegal reports for coroners and others; Craig Easton and Anthony R. Cox have no conflict of interest directly relevant to the content of this study.

Ethical approval

This study was an analysis of publicly available data. No approval was sought.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 532 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ferner, R.E., Easton, C. & Cox, A.R. Deaths from Medicines: A Systematic Analysis of Coroners’ Reports to Prevent Future Deaths. Drug Saf 41, 103–110 (2018). https://doi.org/10.1007/s40264-017-0588-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-017-0588-0